5-hydroxymethylcytosine has been researched along with Myelodysplastic Syndromes in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Liu, S; Liu, X; Luo, Y; Pei, M; Shen, J; Xiao, L; Xu, Y; Yi, Y; Zhang, G; Zheng, W; Zhong, H | 1 |
Calvo, X; Costa, D; Esteve, J; Monzó, M; Muñoz, C; Navarro, A; Nomdedeu, B; Nomdedeu, M; Peña, O; Pereira, A; Risueño, RM; Tejero, R | 1 |
Abdelhay, E; Batalha, AB; Boulhosa, AM; Bueno, AP; Coutinho, DF; Fernandez, TS; Gutiyama, LM; Monte-Mór, BC; Pombo-de-Oliveira, MS; Rouxinol, ST; Vianna, DT; Zalcberg, IR | 1 |
Kriaucionis, S; McClellan, M; Schuster-Boeckler, B; Tomkova, M | 1 |
4 other study(ies) available for 5-hydroxymethylcytosine and Myelodysplastic Syndromes
Article | Year |
---|---|
Decreased 5-hydroxymethylcytosine levels are associated with TET2 mutation and unfavorable overall survival in myelodysplastic syndromes.
Topics: 5-Methylcytosine; Adult; Aged; Aged, 80 and over; Cytosine; Dioxygenases; DNA Methylation; DNA-Binding Proteins; Female; Gene Expression Regulation; Humans; Male; Middle Aged; Mutation; Myelodysplastic Syndromes; Prognosis; Proto-Oncogene Proteins; Young Adult | 2013 |
High levels of global DNA methylation are an independent adverse prognostic factor in a series of 90 patients with de novo myelodysplastic syndrome.
Topics: 5-Methylcytosine; Adult; Aged; Aged, 80 and over; Bone Marrow; Cytosine; DNA; DNA Methylation; Female; Humans; Male; Middle Aged; Myelodysplastic Syndromes; Prognosis; Survival Analysis | 2014 |
TET2 expression level and 5-hydroxymethylcytosine are decreased in refractory cytopenia of childhood.
Topics: 5-Methylcytosine; Adolescent; Case-Control Studies; Child; Child, Preschool; Cytosine; Dioxygenases; DNA Mutational Analysis; DNA-Binding Proteins; Female; Gene Expression Regulation; High-Throughput Nucleotide Sequencing; Humans; Infant; Male; MicroRNAs; Mutation; Myelodysplastic Syndromes; Polymerase Chain Reaction; Proto-Oncogene Proteins; Transcriptome | 2015 |
5-hydroxymethylcytosine marks regions with reduced mutation frequency in human DNA.
Topics: 5-Methylcytosine; Brain Neoplasms; CpG Islands; Databases, Genetic; DNA Methylation; DNA, Neoplasm; Epigenesis, Genetic; Exome Sequencing; Humans; Kidney Neoplasms; Mutation Rate; Myelodysplastic Syndromes; Myeloid Cells | 2016 |